Cargando…
Real-world safety and effectiveness analysis of low-dose preschool sesame oral immunotherapy
BACKGROUND: Previous studies support the effectiveness of sesame oral immunotherapy (S-OIT) in patients >4 years old using maintenance doses of 1200 mg protein. However, tahini is often not palatable to children, and high-maintenance doses may not be possible for preschoolers. OBJECTIVE: We studi...
Autores principales: | Chua, Gilbert T., Soller, Lianne, Kapur, Sandeep, McHenry, Mary, Rex, Gregory A., Cook, Victoria E., Cameron, Scott B., Chan, Edmond S., Yeung, Joanne, Erdle, Stephanie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616424/ https://www.ncbi.nlm.nih.gov/pubmed/37915725 http://dx.doi.org/10.1016/j.jacig.2023.100171 |
Ejemplares similares
-
Risk factors associated with safety of preschool peanut oral immunotherapy
por: Karunakaran, Duva, et al.
Publicado: (2023) -
Home-Based Peanut Oral Immunotherapy for Low-Risk Peanut-Allergic Preschoolers During the COVID-19 Pandemic and Beyond
por: Chua, Gilbert T., et al.
Publicado: (2021) -
Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A review of recent Canadian real-world literature
por: Kovaltchouk, Uliana, et al.
Publicado: (2023) -
Safety and effectiveness of the Canadian food ladders for children with IgE-mediated food allergies to cow’s milk and/or egg
por: Chomyn, Alanna, et al.
Publicado: (2023) -
Patient selection for milk and egg ladders using a food ladder safety checklist
por: Chua, Gilbert T., et al.
Publicado: (2022)